Sodium Valproate Tablets IP 500 mg Exporter

Sodium Valproate Tablets IP 500 mg Exporter in India – Healthy Inc

Sodium Valproate Tablets IP 500 mg Exporter product packaging

Sodium Valproate Tablets IP 500 mg | Exporter

Product image for Sodium Valproate Tablets IP 500 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameSodium Valproate
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049081
PharmacopoeiaIP
Product TypeTablet
CategoryAntiepileptic drugs
SubcategoryAntiepileptic drugs
Active IngredientSodium Valproate
Strength500 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntiepileptic drugs

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Sodium Valproate Tablets IP 500 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Management of generalized tonic-clonic, focal, and absence epileptic seizures. 2. Adjunctive treatment in trigeminal neuralgia, neuropathic pain, and mood stabilization.
Full Description

Healthy Inc invites international procurement enquiries for Sodium Valproate Tablets IP 500 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameSodium Valproate
CompositionSodium Valproate
Strength500 mg
CategoryAntiepileptic drugs
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Sodium Valproate Tablets IP 500 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally at regular scheduled intervals daily. Swallow whole with water; maintain consistent dosing to achieve stable therapeutic anticonvulsant plasma concentrations.
Side EffectsCommon: Drowsiness, fatigue, ataxia, dizziness, diplopia, nausea. Uncommon: Tremor, cognitive slowing, skin rash, mild transaminase elevation. Rare: Stevens-Johnson syndrome, hepatotoxicity, pancreatitis, aplastic anemia.
Warnings and PrecautionsAbrupt Discontinuation: Never stop abruptly; gradual withdrawal over weeks is required to avoid precipitating status epilepticus. Suicidal Ideation: Monitor closely for emergence of depressive mood changes or suicidal thoughts. Hepatic & Hematologic Testing: Regular blood counts and liver enzymes are recommended.
Contraindications1. Known hypersensitivity to Sodium Valproate or related anticonvulsant chemical structures.
2. Acute intermittent porphyria or atrioventricular conduction block.
3. Severe hepatic impairment or preexisting bone marrow depression.
Drug Interactions1. Other Antiepileptics (Phenytoin, Carbamazepine, Valproate): Mutual metabolic induction or inhibition requiring serum monitoring.
2. Oral Contraceptives: Enzyme-inducing anticonvulsants decrease contraceptive hormone efficacy.
3. CNS Depressants & Alcohol: Marked intensification of central nervous system depression.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Sodium Valproate Tablets IP 500 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Sodium Valproate Tablets IP 500 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Sodium Valproate Tablets IP 500 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Sodium Valproate Tablets IP 500 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Sodium Valproate Tablets IP 500 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Hashtags

#Sodium#Exporter#PharmaB2B

Related Products

Latest Posts